⌘K
Loading ticker…
Kyverna Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Kyverna Therapeutics, Inc. Common Stock (KYTX) has a 3-month relative strength percentile of 50 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.7%, relative volume 8.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
50 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
KYTX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $12M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $12M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYTX Jan avg: -14.08% median: -14.08% win: 0% σ: 1.00% n: 2 2024-02-09 → 2026-05-29 | KYTX Feb avg: -6.43% median: -9.43% win: 33% σ: 7.87% n: 3 2024-02-09 → 2026-05-29 | KYTX Mar avg: -11.83% median: -8.58% win: 33% σ: 18.79% n: 3 2024-02-09 → 2026-05-29 | KYTX Apr avg: -5.80% median: 1.97% win: 67% σ: 30.13% n: 3 2024-02-09 → 2026-05-29 | KYTX May avg: -3.34% median: -3.18% win: 33% σ: 13.81% n: 3 2024-02-09 → 2026-05-29 | KYTX Jun avg: -9.88% median: -9.88% win: 50% σ: 42.80% n: 2 2024-02-09 → 2026-05-29 (current) | KYTX Jul avg: 15.88% median: 15.88% win: 100% σ: 0.58% n: 2 2024-02-09 → 2026-05-29 | KYTX Aug avg: -1.68% median: -1.68% win: 50% σ: 7.92% n: 2 2024-02-09 → 2026-05-29 | KYTX Sep avg: 11.31% median: 11.31% win: 50% σ: 71.30% n: 2 2024-02-09 → 2026-05-29 | KYTX Oct avg: 6.96% median: 6.96% win: 50% σ: 13.02% n: 2 2024-02-09 → 2026-05-29 | KYTX Nov avg: 15.38% median: 15.38% win: 100% σ: 7.54% n: 2 2024-02-09 → 2026-05-29 | KYTX Dec avg: -6.31% median: -6.31% win: 50% σ: 40.83% n: 2 2024-02-09 → 2026-05-29 |